Henry Schein Inc (NAS:HSIC)
$ 77.05 -0.61 (-0.79%) Market Cap: 9.61 Bil Enterprise Value: 12.55 Bil PE Ratio: 31.58 PB Ratio: 2.75 GF Score: 83/100

Henry Schein Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 05:00PM GMT
Release Date Price: $66.58 (-1.08%)
Michael Aaron Cherny
BofA Merrill Lynch, Research Division - Director

We'll get started. Thanks, everyone. Welcome to day 2. Welcome back to day 2. I'm Michael Cherny, the healthcare tech and distribution analyst here at Bank of America Merrill Lynch. It's my pleasure to have with us Henry Schein's senior management. We have Stanley Bergman, Chairman and CEO; Steven Paladino, CFO. I think you had a couple of comments you wanted to start with, then we'll dive right into Q&A.

Stanley M. Bergman
Henry Schein, Inc. - Executive Chairman & CEO

Thanks, Mike. I've got very few words on the state of the company and rather handle specific Q&A. So Henry Schein, the largest provider of products now and related services to dentists and laboratories and physicians. We've 3 key component parts of our strategy: one is to advance the value-added service program and our market share globally in dental distribution where the widest variety of products in dentistry all under one roof, consumables, equipment, pharmaceuticals, software, and specialty products,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot